XFOR Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2024-03-11 | Taveras Arthur | officer: Chief Scientific Officer | 234,301 | S-Sale | D | 14,235 | 0.88 | 12,552.00 |
| 2024-03-11 | Ragan Paula | director, officer: President and CEO | 765,068 | S-Sale | D | 49,678 | 0.88 | 43,856.00 |
| 2024-03-11 | Mostafa Adam S. | officer: Chief Financial Officer | 0 | S-Sale | D | 52,500 | 0.88 | 46,347.00 |
| 2024-03-11 | DiBiase Mary | officer: Chief Operating Officer | 291,752 | S-Sale | D | 15,409 | 0.88 | 13,591.00 |
| 2024-02-13 | Arbet-Engels Christophe | officer: Chief Medical Officer | 180,816 | A-Award | A | 180,816 | 0.92 | 166,532.00 |
| 2024-02-13 | Arbet-Engels Christophe | officer: Chief Medical Officer | 475,831 | A-Award | A | 475,831 | 0.92 | 438,240.00 |
| 2024-02-13 | Mostafa Adam S. | officer: Chief Financial Officer | 523,414 | A-Award | A | 523,414 | 0.92 | 482,064.00 |
| 2024-02-13 | DiBiase Mary | officer: Chief Operating Officer | 428,248 | A-Award | A | 428,248 | 0.92 | 394,416.00 |
| 2024-02-13 | Ragan Paula | director, officer: President and CEO | 1,189,578 | A-Award | A | 1,189,578 | 0.92 | 1,095,601.00 |
| 2024-02-13 | Baldry Mark | officer: Chief Commercial Officer | 523,414 | A-Award | A | 523,414 | 0.92 | 482,064.00 |
| 2024-02-13 | Taveras Arthur | officer: Chief Scientific Officer | 428,248 | A-Award | A | 428,248 | 0.92 | 394,416.00 |
| 2024-02-12 | DiBiase Mary | officer: Chief Operating Officer | 307,161 | S-Sale | D | 3,683 | 1.01 | 3,709.00 |
| 2024-02-12 | Taveras Arthur | officer: Chief Scientific Officer | 248,536 | S-Sale | D | 787 | 1.01 | 792.70 |
| 2024-02-12 | Ragan Paula | director, officer: President and CEO | 814,746 | S-Sale | D | 21,695 | 1.01 | 21,892.00 |
| 2024-02-12 | Mostafa Adam S. | officer: Chief Financial Officer | 52,500 | S-Sale | D | 27,721 | 1.01 | 27,973.00 |
| 2023-11-01 | Ragan Paula | director, officer: President and CEO | 876,347 | S-Sale | D | 199,531 | 0.73 | 145,658.00 |
| 2023-11-03 | Ragan Paula | director, officer: President and CEO | 836,441 | S-Sale | D | 39,906 | 0.90 | 35,915.00 |
| 2023-11-01 | Mostafa Adam S. | officer: Chief Financial Officer | 80,221 | S-Sale | D | 230,645 | 0.73 | 168,371.00 |
| 2023-11-01 | DiBiase Mary | officer: Chief Operating Officer | 310,844 | S-Sale | D | 67,695 | 0.73 | 49,417.00 |
| 2023-11-01 | Baldry Mark | officer: Chief Commercial Officer | 24,690 | S-Sale | D | 10,257 | 0.73 | 7,488.00 |
| 2023-11-01 | Taveras Arthur | officer: Chief Scientific Officer | 249,323 | S-Sale | D | 67,695 | 0.73 | 49,417.00 |
| 2023-10-31 | Mostafa Adam S. | officer: Chief Financial Officer | 310,866 | A-Award | A | 230,645 | 0.00 | 0.00 |
| 2023-10-31 | Baldry Mark | officer: Chief Commercial Officer | 34,947 | A-Award | A | 34,947 | 0.00 | 0.00 |
| 2023-10-31 | Taveras Arthur | officer: Chief Scientific Officer | 317,018 | A-Award | A | 230,645 | 0.00 | 0.00 |
| 2023-10-31 | Ragan Paula | director, officer: President and CEO | 1,075,878 | A-Award | A | 532,081 | 0.00 | 0.00 |
| 2023-10-31 | DiBiase Mary | officer: Chief Operating Officer | 378,539 | A-Award | A | 230,645 | 0.00 | 0.00 |
| 2023-10-16 | Woods Keith | director | 90,000 | A-Award | A | 90,000 | 0.00 | 0.00 |
| 2023-10-16 | Woods Keith | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2023-09-08 | DiBiase Mary | officer: Chief Operating Officer | 147,894 | S-Sale | D | 2,642 | 1.25 | 3,300.00 |
| 2023-08-31 | Arbet-Engels Christophe | officer: Chief Medical Officer | 1,250,000 | A-Award | A | 1,250,000 | 1.28 | 1,600,000.00 |
| 2023-08-18 | WYZGA MICHAEL S | director | 76,667 | P-Purchase | A | 25,000 | 1.20 | 29,875.00 |
| 2023-08-16 | Arbet-Engels Christophe | officer | 0 | 0 | 0.00 | 0.00 | ||
| 2023-08-09 | Stewart Murray | director, officer: Interim Chief Medical Officer | 276,560 | A-Award | A | 269,893 | 0.00 | 0.00 |
| 2023-08-10 | Stewart Murray | director, officer: Interim Chief Medical Officer | 146,504 | S-Sale | D | 130,056 | 1.06 | 137,859.00 |
| 2023-06-30 | DiBiase Mary | officer: Chief Operating Officer | 150,536 | S-Sale | D | 464 | 1.89 | 877.00 |
| 2023-06-30 | Mostafa Adam S. | officer: Chief Financial Officer | 80,221 | S-Sale | D | 2,641 | 1.89 | 4,991.00 |
| 2023-06-23 | DiBiase Mary | officer: Chief Operating Officer | 151,000 | S-Sale | D | 857 | 1.93 | 1,654.00 |
| 2023-06-23 | Mostafa Adam S. | officer: Chief Financial Officer | 82,862 | S-Sale | D | 5,417 | 1.93 | 10,455.00 |
| 2023-06-23 | Ragan Paula | director, officer: President and CEO | 543,797 | S-Sale | D | 6,724 | 1.92 | 12,910.00 |
| 2023-06-15 | DiBiase Mary | officer: Chief Operating Officer | 151,857 | S-Sale | D | 857 | 2.23 | 1,911.00 |
| 2023-06-15 | Mostafa Adam S. | officer: Chief Financial Officer | 88,279 | S-Sale | D | 5,417 | 2.22 | 12,026.00 |
| 2023-06-15 | Ragan Paula | director, officer: President and CEO | 550,521 | S-Sale | D | 6,724 | 2.23 | 14,995.00 |
| 2023-06-13 | Aliski William | director | 51,667 | A-Award | A | 45,000 | 0.00 | 0.00 |
| 2023-06-13 | Bridger Gary | director | 51,667 | A-Award | A | 45,000 | 0.00 | 0.00 |
| 2023-06-13 | MCGIRR DAVID W J | director | 51,667 | A-Award | A | 45,000 | 0.00 | 0.00 |
| 2023-06-13 | WYZGA MICHAEL S | director | 51,667 | A-Award | A | 45,000 | 0.00 | 0.00 |
| 2023-06-13 | de Craecker Francoise | director | 51,667 | A-Award | A | 45,000 | 0.00 | 0.00 |
| 2023-06-13 | Lawton Alison Frances | director | 51,667 | A-Award | A | 45,000 | 0.00 | 0.00 |
| 2023-05-31 | Ragan Paula | director, officer: President and CEO | 557,245 | S-Sale | D | 6,292 | 1.95 | 12,269.00 |
| 2023-03-10 | DiBiase Mary | officer: Chief Operating Officer | 152,714 | S-Sale | D | 18,192 | 0.84 | 15,281.00 |
| 2023-03-10 | Mostafa Adam S. | officer: Chief Financial Officer | 93,696 | S-Sale | D | 52,500 | 0.84 | 44,100.00 |
| 2023-03-10 | Taveras Arthur | officer: Chief Scientific Officer | 86,373 | S-Sale | D | 16,806 | 0.84 | 14,117.00 |
| 2023-03-10 | Ragan Paula | director, officer: President and CEO | 563,537 | S-Sale | D | 49,678 | 0.84 | 41,730.00 |
| 2023-02-13 | Taveras Arthur | officer: Chief Scientific Officer | 103,179 | S-Sale | D | 928 | 0.93 | 863.00 |
| 2023-02-13 | DiBiase Mary | officer: Chief Operating Officer | 170,906 | S-Sale | D | 4,348 | 0.93 | 4,044.00 |
| 2023-02-13 | Mostafa Adam S. | officer: Chief Financial Officer | 146,196 | S-Sale | D | 27,721 | 0.93 | 25,781.00 |
| 2023-02-13 | Ragan Paula | director, officer: President and CEO | 613,215 | S-Sale | D | 21,695 | 0.93 | 20,176.00 |
| 2022-11-07 | DiBiase Mary | officer: Chief Operating Officer | 1,350,000 | A-Award | A | 1,350,000 | 0.00 | 0.00 |
| 2022-11-07 | Mostafa Adam S. | officer: Chief Financial Officer | 1,350,000 | A-Award | A | 1,350,000 | 0.00 | 0.00 |
| 2022-11-07 | Taveras Arthur | officer: Chief Scientific Officer | 1,000,000 | A-Award | A | 1,000,000 | 0.00 | 0.00 |
| 2022-11-07 | Ragan Paula | officer: President and CEO | 3,438,335 | A-Award | A | 3,438,335 | 0.00 | 0.00 |
| 2022-11-03 | Baldry Mark | officer: Chief Commercial Officer | 341,000 | A-Award | A | 341,000 | 1.89 | 644,490.00 |
| 2022-11-03 | Baldry Mark | None | 0 | None | None | 0.00 | ||
| 2022-11-03 | Baldry Mark | officer | 0 | 0 | 0.00 | 0.00 | ||
| 2022-08-17 | Meisner Derek M | officer: Chief Legal Officer | 145,155 | S-Sale | D | 8,334 | 0.00 | 0.00 |
| 2022-08-17 | Meisner Derek M | officer: Chief Legal Officer | 145,155 | S-Sale | D | 8,334 | 1.16 | 9,626.00 |
| 2022-08-17 | DiBiase Mary | officer: Chief Operating Officer | 177,896 | S-Sale | D | 1,713 | 0.00 | 0.00 |
| 2022-08-17 | Ragan Paula | officer: President and CEO | 634,910 | S-Sale | D | 13,448 | 0.00 | 0.00 |
| 2022-08-17 | Mostafa Adam S. | officer: Chief Financial Officer | 173,917 | S-Sale | D | 10,834 | 0.00 | 0.00 |
| 2022-06-30 | Mostafa Adam S. | officer: Chief Financial Officer | 184,751 | S-Sale | D | 2,641 | 0.00 | 0.00 |
| 2022-06-30 | DiBiase Mary | officer: Chief Operating Officer | 179,609 | S-Sale | D | 1,578 | 0.00 | 0.00 |
| 2022-06-06 | Bridger Gary | director: | 6,667 | A-Award | A | 6,667 | 0.00 | 0.00 |
| 2022-06-06 | Lawton Alison Frances | director: | 6,667 | A-Award | A | 6,667 | 0.00 | 0.00 |
| 2022-06-06 | WYZGA MICHAEL S | director: | 6,667 | A-Award | A | 6,667 | 0.00 | 0.00 |
| 2022-06-06 | de Craecker Francoise | director: | 6,667 | A-Award | A | 6,667 | 0.00 | 0.00 |
| 2022-06-06 | Stewart Murray | director: | 6,667 | A-Award | A | 6,667 | 0.00 | 0.00 |
| 2022-06-06 | Aliski William | director: | 6,667 | A-Award | A | 6,667 | 0.00 | 0.00 |
| 2022-06-24 | Mostafa Adam S. | officer: Chief Financial Officer | 187,392 | S-Sale | D | 5,416 | 0.00 | 0.00 |
| 2022-06-06 | MCGIRR DAVID W J | director: | 6,667 | A-Award | A | 6,667 | 0.00 | 0.00 |
| 2022-06-24 | DiBiase Mary | officer: Chief Operating Officer | 181,187 | S-Sale | D | 856 | 0.00 | 0.00 |
| 2022-06-24 | Ragan Paula | officer: President and CEO | 648,358 | S-Sale | D | 6,724 | 0.00 | 0.00 |
| 2022-06-24 | Meisner Derek M | officer: Chief Legal Officer | 153,489 | S-Sale | D | 4,166 | 0.00 | 0.00 |
| 2022-06-24 | Meisner Derek M | officer: Chief Legal Officer | 153,489 | S-Sale | D | 4,166 | 1.06 | 4,416.00 |
| 2022-06-16 | Mostafa Adam S. | officer: Chief Financial Officer | 192,808 | S-Sale | D | 5,416 | 0.00 | 0.00 |
| 2022-06-16 | Ragan Paula | officer: President and CEO | 655,082 | S-Sale | D | 6,724 | 0.00 | 0.00 |
| 2022-06-16 | DiBiase Mary | officer: Chief Operating Officer | 182,043 | S-Sale | D | 856 | 0.00 | 0.00 |
| 2022-06-16 | Meisner Derek M | officer: Chief Legal Officer | 157,655 | S-Sale | D | 4,166 | 0.00 | 0.00 |
| 2022-06-16 | Meisner Derek M | officer: Chief Legal Officer | 157,655 | S-Sale | D | 4,166 | 1.01 | 4,208.00 |
| 2022-06-03 | Ragan Paula | officer: President and CEO | 661,806 | S-Sale | D | 6,292 | 1.21 | 7,613.00 |
| 2022-03-01 | DiBiase Mary | officer: Chief Operating Officer | 182,899 | A-Award | A | 105,000 | 0.00 | 0.00 |
| 2022-03-01 | Ragan Paula | officer: President and CEO | 668,098 | A-Award | A | 220,789 | 0.00 | 0.00 |
| 2022-03-01 | Taveras Arthur | officer: Chief Scientific Officer | 104,107 | A-Award | A | 97,000 | 0.00 | 0.00 |
| 2022-03-01 | Mostafa Adam S. | officer: Chief Financial Officer | 198,224 | A-Award | A | 105,000 | 0.00 | 0.00 |
| 2022-03-01 | Cadavid Diego | officer: Chief Medical Officer | 104,107 | A-Award | A | 97,000 | 0.00 | 0.00 |
| 2022-03-01 | Meisner Derek M | officer: Chief Legal Officer | 161,821 | A-Award | A | 105,000 | 0.00 | 0.00 |
| 2022-02-11 | Mostafa Adam S. | officer: Chief Financial Officer | 93,224 | S-Sale | D | 27,721 | 1.52 | 42,136.00 |
| 2022-02-11 | Meisner Derek M | officer: Chief Legal Officer | 56,821 | S-Sale | D | 15,909 | 1.53 | 24,341.00 |
| 2022-02-11 | DiBiase Mary | officer: Chief Operating Officer | 77,899 | S-Sale | D | 12,545 | 1.52 | 19,068.00 |
| 2022-02-11 | Taveras Arthur | officer: Chief Scientific Officer | 7,107 | F-InKind | D | 928 | 0.00 | 0.00 |
| 2022-02-11 | Ragan Paula | director, officer: President and CEO | 447,309 | S-Sale | D | 21,695 | 1.52 | 32,976.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
